retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Today, we shared new data from two trials of retatrutide, our investigational agonist. Learn more at our link in bio Structural insights into the triple

La molcula est aprobada por la FDA para uso en obesidad, pero todava en nuestro pas no tiene esa indicacin

For aggressive fat loss with strong liver fat clearance, 8mg represents the sweet spot

Start retatrutide at 1mg regardless of your previous tirzepatide dose, allow a 7-10 day washout period after your last tirzepatide injection, and follow the standard retatrutide escalation schedule

Food might not sound as appealing as it normally does

For those experiencing anxiety alongside their GLP-1 treatment , the digestive effects can sometimes amplify anxious feelings, particularly the social anxiety around potential embarrassing episodes